Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
According to the World Health Organization (WHO), in the second half of 2022, there are about 606 million confirmed cases of COVID-19 and almost 6,500,000 deaths around the world. A pandemic was declared by the WHO in March 2020 when the new coronavirus spread around the world. The short time betwee...
Main Authors: | Josidel Conceição Oliver, Evandro Neves Silva, Letícia Martins Soares, Gislaine Cristina Scodeler, Ana de Souza Santos, Patrícia Paiva Corsetti, Carlos Roberto Prudêncio, Leonardo Augusto de Almeida |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-12-01
|
Series: | Therapeutic Advances in Vaccines and Immunotherapy |
Online Access: | https://doi.org/10.1177/25151355221144845 |
Similar Items
-
Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
by: Melissa F. Adasme, et al.
Published: (2020-11-01) -
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
by: Sha Zhu, et al.
Published: (2022-01-01) -
Repurposing Drugs to Fight Hepatic Malaria Parasites
by: Diana Fontinha, et al.
Published: (2020-07-01) -
Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
by: Shimei Qin, et al.
Published: (2023-01-01) -
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference
by: Jianhua Wang, et al.
Published: (2022-11-01)